Carl Zeiss Meditec AG (AFX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Carl Zeiss Meditec AG (AFX) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€144.16 Million ≈ $168.54 Million USD) by net assets (€2.13 Billion ≈ $2.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AFX equity financing ratio to measure how much of total assets are equity-financed.
Carl Zeiss Meditec AG - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Carl Zeiss Meditec AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Carl Zeiss Meditec AG's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Carl Zeiss Meditec AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carl Zeiss Meditec AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hawaiian Electric Industries Inc
NYSE:HE
|
0.037x |
|
China Railway Materials Co Ltd
SHE:000927
|
-0.067x |
|
PT Golden Energy Mines Tbk
JK:GEMS
|
0.055x |
|
Ningbo Huaxiang Electronic Co Ltd
SHE:002048
|
0.037x |
|
PSG Konsult Ltd
JSE:KST
|
0.164x |
|
TriNet Group Inc
NYSE:TNET
|
1.795x |
|
Woolworths Holdings Ltd
JSE:WHL
|
0.247x |
|
GN Store Nord
CO:GN
|
0.113x |
Annual Cash Flow Conversion Efficiency for Carl Zeiss Meditec AG (2014–2025)
The table below shows the annual cash flow conversion efficiency of Carl Zeiss Meditec AG from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see AFX stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €2.13 Billion ≈ $2.49 Billion |
€209.86 Million ≈ $245.35 Million |
0.099x | -17.99% |
| 2024-09-30 | €2.06 Billion ≈ $2.40 Billion |
€247.32 Million ≈ $289.14 Million |
0.120x | +4.17% |
| 2023-09-30 | €2.17 Billion ≈ $2.54 Billion |
€250.86 Million ≈ $293.28 Million |
0.115x | +24.53% |
| 2022-09-30 | €2.03 Billion ≈ $2.37 Billion |
€188.20 Million ≈ $220.02 Million |
0.093x | -57.12% |
| 2021-09-30 | €1.68 Billion ≈ $1.96 Billion |
€362.66 Million ≈ $423.99 Million |
0.216x | +75.67% |
| 2020-09-30 | €1.45 Billion ≈ $1.70 Billion |
€178.53 Million ≈ $208.72 Million |
0.123x | -20.60% |
| 2019-09-30 | €1.42 Billion ≈ $1.66 Billion |
€219.63 Million ≈ $256.78 Million |
0.155x | +8.85% |
| 2018-09-30 | €1.31 Billion ≈ $1.54 Billion |
€187.21 Million ≈ $218.86 Million |
0.142x | +368.64% |
| 2017-09-30 | €1.24 Billion ≈ $1.45 Billion |
€37.73 Million ≈ $44.11 Million |
0.030x | -76.86% |
| 2016-09-30 | €851.16 Million ≈ $995.10 Million |
€111.77 Million ≈ $130.67 Million |
0.131x | +84.54% |
| 2015-09-30 | €797.45 Million ≈ $932.30 Million |
€56.74 Million ≈ $66.34 Million |
0.071x | -14.95% |
| 2014-09-30 | €754.23 Million ≈ $881.77 Million |
€63.10 Million ≈ $73.78 Million |
0.084x | -- |
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more